Status: current, Defined. Date: 29-Feb 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4315431000168110 | glycopyrronium bromide + neostigmine (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4315441000168118 | glycopyrronium bromide + neostigmine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| glycopyrronium bromide + neostigmine | Is a | neostigmine | true | Inferred relationship | Some | ||
| glycopyrronium bromide + neostigmine | Is a | glycopyrronium bromide | true | Inferred relationship | Some | ||
| glycopyrronium bromide + neostigmine | has intended active ingredient | neostigmine | true | Inferred relationship | Some | 1867371351 | |
| glycopyrronium bromide + neostigmine | has intended active ingredient | glycopyrronium bromide | true | Inferred relationship | Some | 1856322442 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| glycopyrronium bromide 500 microgram/mL + neostigmine methylsulfate 2.5 mg/mL injection, ampoule | Is a | True | glycopyrronium bromide + neostigmine | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR